Parkinson's Disease Treatment Market Worth 5.69 Billion USD by 2022

Parkinson’s disease therapeutic drugs act upon the central nervous system to control or reduce the symptoms of Parkinson’s disease. The global Parkinson’s disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=47265247

Globally, the Parkinson’s disease treatment market is witnessing a moderate growth due to factors such as increasing prevalence of Parkinson’s disease; rising geriatric population; and support for research on Parkinson’s disease. 

Over the last few decades, key players operating in this market are focusing on offering new and innovative products. Based on drug class, the Parkinson’s disease therapeutic drugs market is segmented into carbidopa/levodopa dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest CAGR during the forecast period. This is due to carbidopa/levodopa drugs are more potent and widely used in the treatment of Parkinson’s disease in comparison to other therapeutic drugs.

By distribution channel, the market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register the highest growth rate during the forecast period. Advancements such as 24/7 availability, home delivery, and discount on medicines are driving factors for online pharmacies segment.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=47265247

On the basis of patient care setting, the market is categorized into hospitals and clinics. The hospitals segment is estimated to grow at the fastest rate during the forecast period. The growth of this segment can be attributed to the availability of diagnostics laboratories in the hospital and the presence skilled neurologists.

The Parkinson’s disease treatment market is classified based on regions into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Presence key market players and rising aging population are the major factors driving the Parkinson’s disease treatment market in this region. 

HIP Replacement Market Forecast to 2020

The report "HIP Replacement Market by Product (Primary HIP Replacement (Cemented, Cementless), Partial HIP Replacement, Revision HIP Replacement, HIP Resurfacing), Geography (Americas, EU-5, Japan, BRIC, South-East Asia, MEA) - Forecast to 2020", The global hip reconstruction devices market was valued at USD 4.8 Billion in 2014, and is estimated to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015 to 2020.

Browse 105 market data tables and 114 figures spread through 228 pages and in-depth TOC on "HIP Replacement Market”
http://www.marketsandmarkets.com/Market-Reports/hip-reconstruction-devices-market-76831539.html
Early buyers will receive 10% customization on reports.

The Global Hip Reconstruction Devices market is expected to witness substantial growth due to increasing number of arthritis patients, favorable reimbursement, and technological advancements

The global hip reconstruction devices market growth is attributed to the rise in the number of patients suffering from arthritis, technological advancements, and favorable reimbursement. Despite this, the pricing pressure, waiting list and risk of complications after implantation are some of the major hindering factors.

The government initiative of allocating new funds and development of new policies have reduced the waiting time for hip reconstructions, and increased the number of operations. However, it is difficult to achieve 90% threshold of patients that receive care within the regulated time.

Get PDF Brochure Here :
http://www.marketsandmarkets.com/pdfdownload.asp?id=76831539

The technological advancements in hip reconstruction market, such as newly developed prostheses with improved strength and reliability of joints are reducing the need and cost of revision surgery. The minimally invasive techniques for hip reconstruction surgery will improve the precision and accuracy of surgeons, thus reducing the time of surgery. The emergence of these techniques and other improved surgical tools for the treatment of arthritis is expected to address the rising demand for surgery during the forecast period.

In 2014, the global hip reconstruction devices market was dominated by North America. This market is segmented and forecast on the basis of product, and geography. The product comprises of primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices and hip resurfacing devices. The primary hip reconstruction devices are subsegmented into cementless and cemented reconstruction device. The market is further segmented and forecast on the basis of major geographies such as North America, Europe, and Asia-Pacific. These major geographies are further sub-segmented into major countries.

The market in North America is growing due to rising pool of arthritis, and favorable reimbursement. The European market is growing due to the technological advancements and is dominated majorly by Zimmer Inc. (U.S.) and Depuy Synthes (U.S.). The Asian market is growing due to growing health awareness among masses, along with increase in the spending capacity of the Indian population. Also, increasing number of population suffering from musculoskeletal disorders (MSD), government initiatives, and rising awareness towards hip reconstruction are propelling the market growth.

Get Sample Report Here :
http://www.marketsandmarkets.com/requestsample.asp?id=76831539

This report also includes the market share, approach for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis and price analysis by product. In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide hip reconstruction devices as a product.

The research study is aimed at identifying emerging trends and opportunities in the global hip reconstruction devices market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hip reconstruction devices market, on the basis of product, and region.

About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Disposable Medical Device Sensors Market Worth 5,936 Million USD by 2020

Factors Of Disposable Medical Device Sensors Market  Growth :

Growing prevalence of diabetes and other infectious diseases across the globe, government support for research and development activities in medical sensors, various benefits such as faster analysis, low costs, ease of use, and rising needs to curtail escalating healthcare costs.

The Disposable Medical Device Sensors   market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020.

Get PDF Brochure Here :http://bit.ly/2yHXtB3

Key Players:

Some of the major players in this market include Medtronic plc. (Ireland), GE Healthcare (U.K.), Philips N.V. (Netherlands), Smiths Medical (U.K.), TE Connectivity (Switzerland), Freescale Semiconductors, Inc. (U.S.), Omnivision Technologies, Inc. (U.S.), STMicroelectronics (Switzerland), Analog Devices, Inc. (U.S.), and Honeywell International, Inc. (U.S.).

Market Geography :            

North America accounted for the largest share of the market in 2014, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The Asia-Pacific region represents the fastest-growing market for disposable medical device sensors, primarily due to the increasing healthcare expenditure, rising medical tourism, increasing awareness among people for self-health management, and growth in the overall healthcare industry. In addition, increasing investments in the healthcare industry by key market players, rising demand for advanced healthcare technologies, and expansion of private sector hospitals to rural areas in countries such as China, Taiwan, and India are driving the growth of this region.

About Report:

The Disposable Medical Device Sensors   market is segmented into patient monitoring devices, diagnostic testing devices, imaging devices, and therapeutic devices. The diagnostic testing devices segment is further divided into HIV test kits, pregnancy test kits, drug and alcohol test kits, and blood glucose test strips.

The therapeutic devices segment is further divided into insulin pump sensors, dialysis device sensors, cardiac therapy devices, and cardiac catheter sensors. The patient monitoring devices segment is categorized into continuous blood pressure monitors, pulse oximeters, cardiac monitors, continuous glucose monitoring devices, implantable loop recorders, smart pills, and others. The imaging devices segment is divided into capsule endoscopes and disposable endoscopes.

To Know More : http://bit.ly/2yJ6I3V

Growing Geriatric Population Driving Home Health Care Market For Patient Best Experience And Its Outcomes

The Major Factors Driving The Growth

 Asian Home Health Care Market  include the rapidly increasing aging population, increasing incidences of chronic diseases, growing demand for affordable healthcare delivery systems due to increasing healthcare costs, technological advancements, and government
The Asian Home Health Care Market  is expected to reach USD 62.32 Billion by 2020 from USD 39.07 Billion in 2015, at a CAGR of 9.8% from 2015 to 2020.

Get PDF Brochure Here: http://bit.ly/2ukMQBN

 Key Players :

Asian Home Health Care Market  include Philips Healthcare (Netherlands), Linde Group (Germany), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), A&D Company Limited (Japan), Fresenius SE & Co. KGaA (Germany), Omron Corporation (Japan), Roche Holdings AG (Switzerland), Portea Medical Pvt. Ltd. (India), Teijin Limited (Japan), and GE Healthcare (U.K.).

About Report :

The Asian home health care market is segmented on the basis of products, services, telehealth, and countries. The telehealth market is projected to grow at the highest CAGR during the forecast period. Growth in Asian home health care market can primarily be attributed to the shift of healthcare delivery from traditional clinical settings to home care, technological advancements, and increasing adoption of telecommunication technologies.

Based on products, the market is further segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. The testing, screening, and monitoring products segment is estimated to account for the largest market share in 2015.

To Know More : http://bit.ly/2vIMY1u

Pyrogen Testing Market - Global Forecasts to 2021

The report "Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021"The global Pyrogen Testing market was valued at USD 610.2 Million in 2016. This market is expected to grow at a CAGR of 12.2% to reach USD 1086.3 Million in 2021.

Browse 74 market data Tables and 95 Figures spread through 173 Pages and in-depth TOC on "Pyrogen Testing Market”
http://www.marketsandmarkets.com/Market-Reports/pyrogen-testing-market-255266155.html
Early buyers will receive 10% customization on this report.

Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market during the forecast period. For instance, the number of new biologics products launched annually witnessed a strong upward trend between 2003 and 2013.

The number of new products launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has increased by 155%, from 355 treatments in 2001 to 907 in 2012. A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industry, which is an important application of pyrogen testing products

Get The Sample Report For This Report@ 
http://www.marketsandmarkets.com/requestsample.asp?id=255266155

The global pyrogen testing market is segmented on the basis of applications, products, tests, and geographies.
By application, the market is divided into pharmaceuticals and biologicals manufacturing, medical devices manufacturing, and other applications such as water purification, food and beverages, cosmetics, and plastics and glass products. Of these, the pharmaceuticals and biologicals manufacturing segment accounted for the largest share of the global pyrogen testing market in 2016. The large share of this segment can primarily be attributed to the rapid growth in pharmaceutical and biotechnology industries.

The test segments included in this report are in vitro pyrogen test, LAL (Limulus Amebocyte Lysate) test, and Rabbit test. Of these the LAL (Limulus amebocyte lysate) test holds the highest share. The large share of LAL test can primarily be attributed to its advantages such as accuracy, speed, requirement of small amount of the tested sample, more economical, and allows detection of lower level of endotoxins, and flexibility in life science research.  The LAL test is further sub-segmented in to chromogenic tests, turbidimetric tests, and gel clot tests.

Get The PDF Brochure For This Report@ 
http://www.marketsandmarkets.com/pdfdownload.asp?id=255266155

The product segments included in the report are kits and reagents, services, and Instruments. The kits & reagents segment commanded the largest share of global pyrogen testing market. The large share of this segment can mainly be attributed to repeat purchase of kits and reagents as compared to instruments, and increasing adoption of kit-based testing.

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada; Europe is further segmented into France, Germany, Italy, Spain, the U.K., and the Rest of Europe (RoE); Asia is further segmented into China, Japan, and India, and the Rest of Asia; and the Rest of the World (RoW) is divided into Africa, Pacific and Oceania, and South America, Central America, and the Caribbean.

Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.)  Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc. (China).

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Current and Future Trends Of Blood Screening Market

The Key Factor For growth Of  Blood Testing Market :

•             Increasing number of blood donations and blood donors

•             Growing affordability and adoption of nucleic acid test (NAT) for blood screening,

•             Rising awareness regarding the safety of donated blood,

•             Growing demand for donated blood, and increasing prevalence/incidence of infectious

              diseases.

Get PDF Brochure Here: http://bit.ly/2w8Bimx

Based on technology, the Blood Testing Market is segmented into NAT, ELISA, rapid tests, western blot assay, and NGS. The ELISA segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this segment include increasing number of donations, growing prevalence of infectious diseases, and the increasing demand for donated blood around the world.

Based on product and service, the Blood Testing Market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment is further subsegmented into NAT, ELISA, and other reagents and kits. The ELISA reagents and kits segment is expected to register the highest growth during the forecast period. This growth can be attributed to the high consumption and repeated use of reagents and kits in blood screening procedures.

Based on region, the Blood Testing Market is segmented into North America, Europe, Asia, and Rest of the World (RoW). The Asian market is expected to grow at the highest CAGR during the forecast period due to increasing prevalence and incidence of infectious diseases, high demand for donated blood, and increased awareness among people regarding the safety of donated blood.

To Know More : http://bit.ly/2vrmNMH

LAL Assays Widely Used for Pyrogen Testing | Asian Market Poised for Rapid Growth

Pyrogen Testing Market, By Product (Instruments, Services, Kits & Reagents), By Test (In Vitro, LAL, Rabbit Test), By Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) – Global Forecast to 2019

Pyrogen testing is mandatory for all drugs and medical devices intended for medical or veterinary use. Pyrogen testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the pyrogen testing market. The growth of this industry will also be aided by increase in number of new drug launches, strong trend of R&D in life science, and increasing government support for the pharmaceutical and biotechnology industries.

Download PDF Brochure :http://www.marketsandmarkets.com/pdfdownload.asp?id=255266155

The test segments included in this report are in vitro pyrogen test, LAL test, and rabbit test. The LAL test will be major revenue pockets for the pyrogen testing market in the forecast period (2014-2019). The LAL test is the most widely used test method in the pyrogen testing market, and is also expected to grow at the highest rate amongst all test segments in this market. In fact, the estimated market size of LAL test in 2019 is expected to be larger than the combined market size of the other two test segments in that year. The Limulus Amebocyte Lysate (LAL) test is gold standard method for detection of bacterial toxins or pyrogens.

The LAL test method is an alternative method for rabbit pyrogen test to detect pyrogens in sterile parenteral drugs. The ease of use of LAL test and its cost advantages over other test like rabbit test makes it the most widely used test in this market. Another important advantage of LAL test over the rabbit test is that LAL test is in accordance with the requirements of the European Pharmacopoeia Commission (Ph. Eur.) for the replacement of the animal-based tests. The Ph. Eur. is in favor of alternative methods where possible.

North America accounted for the largest share of the global pyrogen testing market in 2014. Asia is expected to grow at the highest CAGR in the forecast period for this report (2014–2019), and represents an important revenue pocket for the pyrogen testing market. Asia is expected to witness a steady year-on-year growth, owing to the trend of outsourcing drug discovery research activities to countries in this geography. 

Moreover, an increase in government support for pharmaceutical and biotechnology industries in this region will further fuel the demand for products offered in the pyrogen testing market. For instance, beginning in 2014, the Indian government plans to invest up to $5 billion a year for the next five years, to boost the biotechnology sector in the country and make it a $100 billion industry by 2025. Similarly, the Chinese government is also taking various initiatives to promote life sciences research, and plans to invest more than $300 billion in biotechnology from 2012 to 2017.

To Know More : http://www.marketsandmarkets.com/requestsample.asp?id=255266155

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Surgical Staplers Market | Driven By Increasing Number of Surgical Procedures

Major Factor For The Growth Of Market :
A number of factors such as increasing number of surgical procedures across the globe, growing preference for minimally invasive surgeries, technological advancements, and increasing preference for surgical staplers over sutures are expected to drive the growth of the market. On the other hand, high cost of devices and availability of alternative wound care techniques may hinder the growth of the market in the coming years.

The global Surgical Staplers Market is expected to reach USD 4.78 Billion by 2022 from USD 3.38 Billion in 2017, at a CAGR of 7.2%.

Get PDF Brochure Here : http://bit.ly/2xqTFX7

Key players :
The Surgical Staplers Market  is duopolistic in nature with two major players Ethicon Inc. (U.S.) and Medtronic plc (Ireland). CONMED Corporation (U.S.), Smith & Nephew (U.K.), Purple Surgical Inc. (U.K.), Intuitive Surgical Inc. (U.S.), Welfare Medical Ltd. (U.K.), Reach surgical Inc. (China), Meril Life Science Pvt. Ltd. (India), Grena Ltd. (U.K.), B. Braun Melsungen AG (Germany), Dextera Surgical Inc. (U.S.), Frankenman International (China), and Becton, Dickinson and Company (U.S.) are some of the other players operating in the global Surgical Staplers Market.

About Report :
Based on product, the market is segmented into Manual Surgical Stapler and Powered Surgical Stapler. The manual surgical stapler segment is expected to account for the largest share of the surgical stapler market in 2017. Manual Surgical Staplers are faster, more economical, and cause fewer infections than stitches. It also causes low tissue reactivity, which helps in preventing SSIs as compared to conventional methods available for wound closure such as sutures.

Based on the application, the market is segmented into abdominal & pelvic surgery, general surgery, cardiac and thoracic surgery, orthopedic surgery, and other surgical applications. In 2017, abdominal & pelvic surgery is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to the increasing prevalence of obesity, growing health consciousness across the globe, increasing purchasing power, and growth in the number of bariatric or weight loss surgeries across the globe.

By end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs) & clinics. In 2017, the hospitals segment is expected to account for the largest share of the market. Rapidly increasing patient volume and the subsequent increase in the number of complex surgeries, easy accessibility to multiple specialty treatments in a single facility, and favorable reimbursements are the major factors driving the growth of this end-user segment.

 To Know More : Click Here